-
Comprehensive benchmarking of methods for mutation calling in circulating tumor DNA
Study
EGAS50000001313
-
Balanced_Brain_Tumour_Whole_Genome_Sequencing
Study
EGAS00001000360
-
High throughput profiling of undifferentiated pleomorphic sarcomas identifies two main subgroups with distinct immune contexture, clinical outcome and sensitivity to targeted therapies
Study
EGAS00001004612
-
Single cell Transcriptomic Analysis of Cellular Heterogeneity in Human Colorectal Tumors
Study
EGAS00001001945
-
Breast_Cancer_FRT_RNA_seq
Study
EGAS00001000420
-
Molecular classification of small intestinal adenocarcinomas
Study
EGAS50000001238
-
GCP study
Study
EGAS00001004959
-
CMF_RNA_sequencing
Study
EGAS00001000470
-
Multi-omics analysis of serial samples from metastatic TNBC patients on PARP inhibitor monotherapy provide insight into rational PARP inhibitor therapy combinations
Study
EGAS00001005479
-
Longitudinal single-cell RNA-seq data of metastatic ovarian cancer
Study
EGAS00001005006
-
Colorectal cancer functional annotation - Micro-C
Study
EGAS50000000206
-
Colorectal cancer functional annotation - ChIP
Study
EGAS50000000207
-
Colorectal cancer functional annotation - ATAC
Study
EGAS50000000205
-
Colorectal cancer functional annotation - RNAseq
Study
EGAS50000000208
-
CELM
Study
EGAS00001002261
-
DO NOT USE - Whole genome sequencing of SI-NETs from five patients
Study
EGAS00001004435
-
DO NOT USE - Whole genome sequencing of SI-NETs from six patients
Study
EGAS00001005009
-
Next_gen_seq_of_eye_cancers
Study
EGAS00001002309
-
Chromatin accessibility of clear cell renal cell carcinoma
Study
EGAS50000001325
-
TMD_AMKL_targeted_follow_up_part_2
Study
EGAS00001000732
-
The Ovarian Cancer Association Consortium OncoArray genome-wide association study
Study
EGAS00001002305
-
MPN_TGS2_Follow_up___PT1_Vori_other
Study
EGAS00001000765
-
Two lung cancer cell lines with EGFR mutations, PC-9 and KHM-3S, were either treated with Tarceva for 24 hours or left untreated. The gene expression profiles were examined by RNAseq, and the genome wide binding profiles of total STAT3 and pSTAT3 were characterized by ChIPseq.
Study
EGAS00001000793
-
Specific BRCA and immune configurations determine optimal response to platinum-based chemotherapy in triple negative breast and ovarian carcinomas (COH_TNBC_RNAseq)
Study
EGAS00001006002
-
In this study, we performed exon sequencing (WXS) of 80 paired Brain cancer tumors and adjacent normal tissues to identify novel potential biomarkers. We extracted mutational signatures which induce somatic mutations . Our study covers a comprehensive genetic framework that can be used in clinical trials and treatment modalities in Brain cancer.
Study
EGAS00001002352